Novo Nordisk A/S (NYSE:NVO)

47.16
Delayed Data
As of Apr 26
 +0.28 / +0.60%
Today’s Change
37.27
Today|||52-Week Range
58.37
-12.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Operating ActivitiesNet Income / Starting Line1.5B1.5B1.6B1.3B
 
 
 
 
 
Depreciation102.0M129.2M112.9M95.5M
 
 
 
 
 
Total Other Cash Flow192.7M136.1M403.4M-452.4M
 
 
 
 
 
Funds From Operations1.8B1.8B2.1B1.0B
 
 
 
 
 
Funds From/For Other Operating Expenses13.0M234.7M29.8M35.8M
 
 
 
 
 
Net Cash Flow - Operating Activities1.7B1.5B2.0B996.2M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-5.9M5.9M0.00
 
 
 
Decrease In Investments144.9M152.0M6.3M4.6M
 
 
 
 
 
Capital Expenditures-231.0M-233.9M-306.2M-397.1M
 
 
 
 
 
Fixed Asset Disposal----23.8K471.9K
 
 
 
Other Investing - Uses0.000.00-6.0M-82.0K
 
 
 
Other Investing - Sources0.000.001.7M9.5M
 
 
 
Net Cash Flow Investing-101.7M-108.9M-308.4M-491.6M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-611.4M-566.8M-672.4M-730.1M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-1.6B-36.1M-1.2B-38.6M
 
 
 
 
 
Other Sources - Financing283.5M-283.5M0.000.00
 
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-2.0B-886.3M-1.8B-768.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash1.2M-25.0M-10.8M2.3M
 
 
 
 
 
 
Net Change In Cash-334.0M532.0M-101.1M-264.2M